Clinical Trial Update: ENA-001 for Opioid Induced Respiratory Depression [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ENA-001 evaluating treatment for opioid-induced respiratory depression. The study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Respiratory Depression

Drugs mentioned

• ENA-001

Snippet

Sponsor: Enalare Therapeutics Inc. | Conditions: Respiratory Depression | Phase 1 | Status: ACTIVE_NOT_RECRUITING